CRS – Sixth GCIG Ovarian Cancer Consensus Conference

October 15 – 21, 2021

This topic has 1 reply, 2 voices, and was last updated 4 years, 10 months ago by Ignace Vergote.

Viewing 0 reply threads

Author

Posts
- October 17, 2021 at 9:41 am #1186
  
  Ignace Vergote
  Participant
  
  I agree that CRS score and complete pathological response at IDS should be added as possible (secondary) endpoints .
Author

Posts

Viewing 0 reply threads

You must be logged in to reply to this topic.

X